FDA biologics centre tries to stabilise under new acting director after Prasad era

Karim Mikhail, acting director of the FDA's Center for Biologics Evaluation and Research, is working to steady the centre after the turbulent tenure of his predecessor Vinay Prasad. At a June town hall he told staff he was "on planet Earth" with them and understood their situation. The full story is available to STAT+ subscribers.

Similar stories

🏥 Health FDA approves Moderna's mRNA flu vaccine — a first for the technology STAT News · 1d ago 🏥 Health Cyclospora outbreak in US: 23,000 cases, 2 deaths, shredded iceberg lettuce to blame National Geographic PL · 4h ago 🏥 Health FDA approves Takeda's Orzeyful, a novel orexin-based pill for type 1 narcolepsy STAT News · 1d ago